CD274 and infection: The onset of clinical symptoms of TMEV-IDD was comparable in anti-B7-H1 mAb and control mice (Figure 8), however the severity of clinical disease was significantly increased in the chronic phase of disease (>day 55–60 post-infection) and this was also reflected by histopathological examination of inflammation and demyelination (data not shown).